At close: December 20 at 3:29:01 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-18,494.62
-14,747.69
-7,874.69
-4,018.34
-1,675.18
Investing Cash Flow
100.39
-458.35
-351.73
134.06
-13.91
Financing Cash Flow
42,113.17
20,396.28
6,291.47
6,735.16
3,791.23
End Cash Position
38,203.21
9,310.28
4,120.04
6,054.99
3,204.12
Capital Expenditure
-25.62
-458.35
-351.73
-5.98
-13.91
Issuance of Capital Stock
42,849.33
20,669.37
6,528.85
7,174.75
4,127.14
Issuance of Debt
--
--
--
--
100.00
Repayment of Debt
--
--
--
--
-400.00
Free Cash Flow
-18,520.24
-15,206.04
-8,226.43
-4,024.33
-1,689.09
12/31/2020 - 12/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6JH.SG IN8bio Inc
0.2280
-10.24%
6JH.BE IN8bio Inc
0.2340
-2.50%
174900.KQ AbClon Inc.
13,760.00
-1.92%
CRTHF CARsgen Therapeutics Holdings Limited
0.7465
0.00%
IUL.BE ImmuCell Corp
4.3600
+3.32%
CY71.F Anixa Biosciences, Inc.
2.5600
+6.67%
6JH.MU IN8bio, Inc.
0.2360
-10.61%
IMR.F AC Immune SA
2.6750
+2.29%
IMR.SG AC Immune SA
2.5700
-2.84%
S09.F Sutro Biopharma, Inc.
1.7000
-9.09%